Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

BigBear.ai Before Q2 Earnings: Buy, Sell or Hold the Stock?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/012f8213-0bd1-4831-98f2-6d5fae956d6a.png
BigBear.ai Before Q2 Earnings: Buy, Sell or Hold the Stock?

BigBear.ai Holdings, Inc. BBAI is scheduled to report second-quarter 2025 results on Aug. 11, after the closing bell, and the key focus will be on whether the company’s recent strategic alignment

Zillow Misses Q2 Earnings Estimates Despite Higher Revenues
Zillow Misses Q2 Earnings Estimates Despite Higher Revenues

Zillow Group, Inc. ZG reported mixed second-quarter 2025 results, wherein the bottom line missed the Zacks Consensus Estimate but the top line beat the same. The company registered a healthy

Saga Communications (SGA) Q2 Earnings and Revenues Lag Estimates
Saga Communications (SGA) Q2 Earnings and Revenues Lag Estimates

Saga Communications (SGA) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.4 per share a year ago. These

Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/YPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y

Catalyst Pharmaceuticals CPRX reported adjusted earnings of 68 cents per share for the second quarter of 2025, beating the Zacks Consensus Estimate of 58 cents. The company had recorded adjusted

Evergy's Q2 Earnings Beat Estimates, Revenues Decrease Y/Y
Evergy's Q2 Earnings Beat Estimates, Revenues Decrease Y/Y

Evergy, Inc. EVRG reported second-quarter 2025 operating earnings per share (EPS) of 82 cents, which topped the Zacks Consensus Estimate of 76 cents by 7.9%. In the year-ago quarter, the company

ConocoPhillips Q2 Earnings Beat Estimates, Revenues Improve Y/Y
ConocoPhillips Q2 Earnings Beat Estimates, Revenues Improve Y/Y

ConocoPhillips COP reported second-quarter 2025 adjusted earnings per share of $1.42, which beat the Zacks Consensus Estimate of $1.36. The bottom line decreased from the prior-year level of $1.98.

UGI Q3 Loss Narrower Than Expected, Revenues Miss Estimates
UGI Q3 Loss Narrower Than Expected, Revenues Miss Estimates

UGI Corporation UGI reported a third-quarter fiscal 2025 operating loss of a cent per share, which was narrower than the Zacks Consensus Estimate of a loss of 12 cents. In the year-ago quarter, the

Cresco Labs Inc. (CRLBF) Reports Q2 Loss, Lags Revenue Estimates
Cresco Labs Inc. (CRLBF) Reports Q2 Loss, Lags Revenue Estimates

Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.16 per share a year ago. These

Kinder Morgan's Expanding Backlog: Powering the LNG & Electricity Boom
Kinder Morgan's Expanding Backlog: Powering the LNG & Electricity Boom

Kinder Morgan Inc. KMI, a leading midstream energy company, has seen a surge in its project backlog in the June quarter of 2025. The backlog grew to $9.3 billion from $8.8 billion, reflecting strong

Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue GrowthPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth

Acadia Pharmaceuticals ACAD reported second-quarter 2025 earnings of 16 cents per share, which beat the Zacks Consensus Estimate of 14 cents. In the year-ago quarter, the company had reported

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

SAB Biotherapeutics, Inc. (SABS) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus

Will Ontrak, Inc. (OTRK) Report Negative Q2 Earnings? What You Should Know
Will Ontrak, Inc. (OTRK) Report Negative Q2 Earnings? What You Should Know

Wall Street expects a year-over-year increase in earnings on lower revenues when Ontrak, Inc. (OTRK) reports results for the quarter ended June 2025. While this widely-known consensus outlook is

Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline
Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline

The market expects Dianthus Therapeutics, Inc. (DNTH) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known

Birkenstock (BIRK) Reports Next Week: Wall Street Expects Earnings Growth
Birkenstock (BIRK) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Birkenstock (BIRK) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus

Atlanticus Holdings Corporation (ATLC) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Atlanticus Holdings Corporation (ATLC) Earnings Expected to Grow: What to Know Ahead of Q2 Release

The market expects Atlanticus Holdings Corporation (ATLC) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This

Globant (GLOB) Reports Next Week: Wall Street Expects Earnings Growth
Globant (GLOB) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Globant (GLOB) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is

Tapestry (TPR) Earnings Expected to Grow: Should You Buy?
Tapestry (TPR) Earnings Expected to Grow: Should You Buy?

The market expects Tapestry (TPR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is

Life360 (LIF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Life360 (LIF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Life360 (LIF) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a

Cogent (CCOI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Cogent (CCOI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Cogent Communications (CCOI) reported revenue of $246.25 million, down 5.5% over the same period last year. EPS came in at -$1.21, compared to -$0.75 in the year-ago

Piedmont Lithium Inc. - Sponsored ADR (PLL) Expected to Beat Earnings Estimates: Should You Buy?Photo, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Piedmont Lithium Inc. - Sponsored ADR (PLL) Expected to Beat Earnings Estimates: Should You Buy?

Piedmont Lithium Inc. - Sponsored ADR (PLL) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known

GCM Grosvenor (GCMG) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
GCM Grosvenor (GCMG) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

GCM Grosvenor Inc. (GCMG) reported $119.66 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 2.3%. EPS of $0.16 for the same period compares to $0.15 a

Amcor (AMCR) Reports Next Week: What Awaits?
Amcor (AMCR) Reports Next Week: What Awaits?

The market expects Amcor (AMCR) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus

P10 (PX) Reports Q2 Earnings: What Key Metrics Have to Say
P10 (PX) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, P10, Inc. (PX) reported revenue of $72.7 million, up 2.3% over the same period last year. EPS came in at $0.23, compared to $0.24 in the year-ago quarter.

The

Here's What Key Metrics Tell Us About UWM (UWMC) Q2 Earnings
Here's What Key Metrics Tell Us About UWM (UWMC) Q2 Earnings

For the quarter ended June 2025, UWM Holdings Corporation (UWMC) reported revenue of $758.7 million, up 49.6% over the same period last year. EPS came in at $0.16, compared to $0.04 in the year-ago

Compared to Estimates, Parker-Hannifin (PH) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Parker-Hannifin (PH) Q4 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Parker-Hannifin (PH) reported revenue of $5.24 billion, up 1.1% over the same period last year. EPS came in at $7.69, compared to $6.77 in the year-ago quarter.

The